BR112012016918A2 - detecção do risco de pré-eclâmpsia - Google Patents

detecção do risco de pré-eclâmpsia

Info

Publication number
BR112012016918A2
BR112012016918A2 BR112012016918A BR112012016918A BR112012016918A2 BR 112012016918 A2 BR112012016918 A2 BR 112012016918A2 BR 112012016918 A BR112012016918 A BR 112012016918A BR 112012016918 A BR112012016918 A BR 112012016918A BR 112012016918 A2 BR112012016918 A2 BR 112012016918A2
Authority
BR
Brazil
Prior art keywords
preeclampsia
risk detection
risk
detection
Prior art date
Application number
BR112012016918A
Other languages
English (en)
Inventor
David Broadhurst
Louise Kenny
Philip Newton Baker
Original Assignee
Univ College Cork Nat Univ Ie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cork Nat Univ Ie filed Critical Univ College Cork Nat Univ Ie
Publication of BR112012016918A2 publication Critical patent/BR112012016918A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
BR112012016918A 2009-12-21 2010-12-21 detecção do risco de pré-eclâmpsia BR112012016918A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28846509P 2009-12-21 2009-12-21
PCT/EP2010/070446 WO2011080170A1 (en) 2009-12-21 2010-12-21 Detection of risk of pre-eclampsia

Publications (1)

Publication Number Publication Date
BR112012016918A2 true BR112012016918A2 (pt) 2016-04-12

Family

ID=43587630

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012016918A BR112012016918A2 (pt) 2009-12-21 2010-12-21 detecção do risco de pré-eclâmpsia

Country Status (8)

Country Link
US (3) US9262582B2 (pt)
EP (3) EP2517019A1 (pt)
JP (3) JP5756125B2 (pt)
CN (1) CN102893156A (pt)
BR (1) BR112012016918A2 (pt)
ES (1) ES2970328T3 (pt)
RU (1) RU2012131290A (pt)
WO (2) WO2011075842A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2517019A1 (en) * 2009-12-21 2012-10-31 University College Cork, National University Of Irland Cork Detection of risk of pre-eclampsia
BR112014012732A8 (pt) * 2011-11-30 2017-06-20 Koninklijke Philips Nv método para determinar pelo menos um parâmetro que seja adequado como uma base para identificar gestações de alto risco e sistema para identificar gestações de alto risco
EP2836832A4 (en) * 2012-04-13 2015-10-14 Univ Wayne State DETECTION OF PREGNANCY OF EARLY OR LATE PRE-ECHAMPSIA
CA2871878C (en) * 2012-06-27 2021-08-10 F. Hoffmann-La Roche Ag Means and methods applying sflt-1/pigf or endoglin/pigf ratio to rule-out onset of preeclampsia within a certain time period
CN103513042A (zh) * 2013-09-23 2014-01-15 中国科学院动物研究所 用于预测或早期诊断妊娠高血压疾病的试剂盒
US20170205420A1 (en) * 2014-06-23 2017-07-20 Wallac Oy Biochemical markers for use in determining risk of diabetes
RU2558465C1 (ru) * 2014-07-15 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования Читинская государственная медицинская академия Министерства здравоохранения РФ Способ доклинической диагностики преэклампсии
US20170299607A1 (en) * 2014-09-24 2017-10-19 Map Ip Holding Limited Methods For Providing A Prognosis Of Pregnancy
US20180114600A1 (en) * 2015-03-23 2018-04-26 Adelaide Research & Innovation Pty Ltd Methods and systems for determining risk of a pregnancy complication occurring
AU2016344373A1 (en) * 2015-10-26 2018-05-24 Brigham Young University Serum lipid biomarkers of preeclampsia
GB201600882D0 (en) 2016-01-18 2016-03-02 Power Box Ag Improvements to router apparatus
EP3730944B1 (en) * 2016-04-13 2021-12-29 Abbott Laboratories Cardiac troponin i detection during pregnancy for cardiovascular disease identification and risk assessment
US10978202B2 (en) * 2016-04-21 2021-04-13 Perigen Inc. Method and system for concurrently monitoring multiple obstetrics patients
WO2018071845A1 (en) * 2016-10-13 2018-04-19 Krishnamurti Tamar Priya A structured medical data classification system for monitoring and remediating treatment risks
RU2638785C1 (ru) * 2016-12-12 2017-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии тяжелого течения
CN106755492B (zh) * 2017-01-24 2020-04-21 深圳金蕊科技有限公司 用于预测子痫前期的成套snp及其应用
WO2018174876A1 (en) * 2017-03-22 2018-09-27 Mprobe Inc. Methods and compositions for providing a preeclampsia assessment with metabolites
JP2018175850A (ja) * 2017-04-14 2018-11-15 株式会社Ｎｔｔドコモ データ収集装置及びデータ収集方法
JP2019041754A (ja) * 2017-08-31 2019-03-22 株式会社Ｎｔｔドコモ 予測装置及び予測方法
US11341138B2 (en) * 2017-12-06 2022-05-24 International Business Machines Corporation Method and system for query performance prediction
GB201802123D0 (en) * 2018-02-09 2018-03-28 Metabolomic Diagnostics Ltd A method of processomg a biological sample
CN112105931A (zh) * 2018-02-09 2020-12-18 代谢组学诊断有限公司 用代谢生物标记物和蛋白质生物标记物预测子痫前期早产的方法
EP3865127A4 (en) * 2018-06-21 2023-01-11 Maruha Nichiro Corporation MEANS OF PRESERVING AND PROTECTING KIDNEY FUNCTION AND METHODS OF EVALUATION OF ITS EFFECTS
JP7013416B2 (ja) * 2018-06-21 2022-01-31 マルハニチロ株式会社 腎機能維持及び保護剤、並びに、その効果評価方法
JP2021532378A (ja) * 2018-07-20 2021-11-25 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Ｉｇｆｂｐ−７に基づく妊娠高血圧腎症の予測
KR102308865B1 (ko) * 2019-02-08 2021-10-05 서울대학교산학협력단 전신 홍반 루푸스 산모의 임신 위험도를 평가하는 방법
CN110534184B (zh) * 2019-08-29 2022-07-15 中国人民解放军陆军军医大学第一附属医院 一种产科手术资源配置预测系统
CN110806456B (zh) * 2019-11-12 2022-03-15 浙江工业大学 一种UPLC-HRMS Profile模式非靶向代谢轮廓数据自动解析的方法
AU2021225366A1 (en) * 2020-02-28 2022-10-06 Metabolomic Diagnostics Limited Prediction of risk of pre-eclampsia
CN112820406A (zh) * 2020-12-30 2021-05-18 复旦大学附属妇产科医院 一种妊娠早期对子痫前期发病风险的预测方法
CN113092777B (zh) * 2021-03-26 2023-11-14 泰达国际心血管病医院 孕早期进行重症子痫前期患者筛查的方法
CN117233367B (zh) * 2023-11-16 2024-02-09 哈尔滨脉图精准技术有限公司 妊娠期高血压风险评估的代谢标志物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068653A1 (en) * 2000-06-01 2003-04-10 Parrott Jeff A. Determining existence of complications in pregnancies by measuring levels of bioactive lipids
DE10043124A1 (de) * 2000-08-31 2002-03-14 Max Delbrueck Centrum Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase
WO2006086731A2 (en) * 2005-02-09 2006-08-17 The Gov't.T Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Method for identifying the risk of preterm delivery
CN101263391A (zh) * 2005-09-12 2008-09-10 菲诺梅诺米发现公司 通过测量维生素e-相关的代谢物诊断结肠直肠癌和卵巢癌的方法
CA2644499A1 (en) * 2006-03-02 2007-09-13 Perkinelmer Las, Inc. Methods for distinguishing isomers using mass spectrometry
GB0612669D0 (en) * 2006-06-27 2006-08-09 Univ Leeds Biomarkers for preeclampsia
GB0613165D0 (en) * 2006-06-28 2006-08-09 Univ Warwick Real-time infrared measurement and imaging system
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
CN101122600A (zh) * 2007-08-16 2008-02-13 复旦大学附属中山医院 一种血清小分子代谢产物的检测方法
EP2517019A1 (en) * 2009-12-21 2012-10-31 University College Cork, National University Of Irland Cork Detection of risk of pre-eclampsia

Also Published As

Publication number Publication date
WO2011075842A1 (en) 2011-06-30
US20190056380A1 (en) 2019-02-21
EP2517019A1 (en) 2012-10-31
JP5756125B2 (ja) 2015-07-29
EP3206033A1 (en) 2017-08-16
RU2012131290A (ru) 2014-01-27
JP2016014685A (ja) 2016-01-28
CN102893156A (zh) 2013-01-23
JP2013515255A (ja) 2013-05-02
US20130073212A1 (en) 2013-03-21
EP3422006A1 (en) 2019-01-02
US20160223517A1 (en) 2016-08-04
JP2015038512A (ja) 2015-02-26
ES2970328T3 (es) 2024-05-28
EP3422006B1 (en) 2023-11-01
WO2011080170A9 (en) 2012-07-12
US10564146B2 (en) 2020-02-18
JP5815830B2 (ja) 2015-11-17
JP6185532B2 (ja) 2017-08-23
WO2011080170A1 (en) 2011-07-07
US9262582B2 (en) 2016-02-16
EP3422006C0 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
BR112012016918A2 (pt) detecção do risco de pré-eclâmpsia
GB2517100B (en) Method of optical sensing
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
ZA201202816B (en) Detection of objects
BRPI1011694A2 (pt) similadores de categoria
CR20120576A (es) Inhibidores de pirazolil quinazolina cinasa
BR112013008154A2 (pt) sensores de integração em tecidos
BRPI1009197A2 (pt) preparação de ácido alfa-cetopimélico
BRPI1012902A2 (pt) conjuntos de sensor de desenvolvimento
DK2482768T3 (da) Intrauterint system
EP2596117A4 (en) METHOD FOR DETECTING NIERGENICAL DISEASES OR SUFFERING
BRPI1009873A2 (pt) detecção aperfeiçoada de expressão gênica
BRPI1008744A2 (pt) hidrotratamento de caboidratos
DK2575438T3 (da) Forbedret detekteringssystem
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
IT1398296B1 (it) Disposizione di sensori
DK2519512T3 (da) N1-acyl-5-fluorpyrimidinonderivater
BR112012031835A2 (pt) indicador de ruptura
DK2453858T3 (da) Fremgangsmåde
DK2429726T3 (da) Rørsystem
BR112013029333A2 (pt) detecção de nível
BR112012010524A2 (pt) compostos derivados de quinazolina
BR112013015580A2 (pt) método de radioestabilização
BR112013007492A2 (pt) glicodendrímeros de polipropileterimina
BR112012026309A2 (pt) roupa de baixo

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL